Search filters

List of works by Elena Geuna

A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies.

scientific article published on 10 May 2017

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

scientific article published on 10 April 2017

Buparlisib , an oral pan-PI3K inhibitor for the treatment of breast cancer

scientific article

Clinical utility of exemestane in the treatment of breast cancer

scientific article published on 27 May 2015

Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

scientific article

Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer

scientific article published on October 1, 2012

FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer

scientific article published in February 2014

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.

scientific article published on 9 October 2017

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.

scientific article

Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer

scientific article published on 10 February 2016

Linifanib: current status and future potential in cancer therapy

scientific article published on 02 May 2015

Metastatic breast cancer subtypes and central nervous system metastases

scientific article published on 30 June 2014

New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer.

scientific article published on 20 September 2016

Omission of axillary dissection after a positive sentinel lymph-node: Implications in the multidisciplinary treatment of operable breast cancer

scientific article published on 24 May 2016

Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions.

scientific article

Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?

scientific article published on 15 June 2017

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

scientific article

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

scientific article published on 20 July 2018

The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.

scientific article

Trastuzumab Beyond Progression in Retrospective Analyses: An Issue of Equal Opportunities

scientific article published on March 10, 2011

What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

scientific article published on 06 November 2018